Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From hVIVO Plc
ENA Respiratory expects its "preventive" nasal spray, which primes innate immunity against respiratory viruses including SARS-CoV-2, to play a meaningful role in protecting at-risk populations and lowering community transmission of COVID-19. It plans to explore the potential of the broad-spectrum antiviral immunomodulator in other areas, including COPD, and wider partnering opportunities.
The SEEK spin-out ConserV Bioscience is developing a broad-spectrum coronavirus vaccine, aiming to get ahead of the arrival of new strains of the virus.
Brief summaries of recent product and company developments in the device industry, including a rift in the orthopedics industry following the DOJ settlement, new OTC aesthetics devices, and MannKind's prospects for partnering its inhaled insulin.
Summary of recent device mergers and acquisitions, alliances, and financings.
- Other Names / Subsidiaries
- Imutex Limited
- Open Orphan plc
- Retroscreen Virology Group plc